Strong Trigger
now
Gains historic accelerated FDA approval for 'Rezdiffra', the first-ever drug for NASH/MASH, ensuring high commercial exclusivity across major US insurance coverages.
24h Trigger History
No history available
No trigger updates found for this ticker in the last 24 hours.
| Advertisement |